Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
16.3 Literatur
Arbeitsgemeinschaft der wissenschaftlichen Medizinischen Fachgesellschaften/AWMF (2000) Interdisziplinäre kurzgefaßte Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Urologie. Nierenzellkarzinom. AWMF-Leitlinien-Register Nr. 032/037, 2000, A25 331 ff.
Bonsib SM, Gibson D, Mhoon M, Greene GF (2000) Renal sinus involvement in renal cell carcinomas. Am J Surg Pathol 24:451–458
Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57:339–344
Flanigan RC, Salmon SE, Blumenstein BA et al. (2001) Nephrectomy followed by interferon alfa-2 b compared with interferon alfa-2 b alone for metastatic renal-cell cancer. N Engl J Med 345:1655–1659
Gleave ME, Elhilali M, Fradet Y et al. (1998) Interferon gamma-1 b compared with placebo in metastatic renalcell carcinoma. Canadian Urologic Oncology Group. N Engl J Med 338:1265–1271
Hafez KS, Fergany AF, Novick AC (1999) Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 162:1930–1933
Maher ER, Yates JR, Harries R, Benjamin C et al. (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–11–63
Maher ER, Webster AR, Moore AT (1995) Clinical features and molecular genetics of Von Hippel-Lindau disease. Ophthalmic Genet 16:79–84
Matson MA, Cohen EP (1990) Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore) 69:217–226
Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966–970
Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R (1997) Brain metastases in renal cell carcinoma. Results of treatment and prognosis. Urologe (A) 36:117–125
Riese W, Goldenberg K, Freytag A (1998) Spontanremissionen und deren Einfluß auf die Prognose von Patienten mit metastasiertem Nierenzellkarzinom. In: Heim M, Schwarz R (Hrsg) Spontanremissionen in der Onkologie. Schattauer, Stuttgart, S 223–240
Schlichter A, Wunderlich H, Junker K, Kosmehl H, Zermann DH, Schubert J (2000) Where are the limits of elective nephron-sparing surgery in renal cell carcinoma? Eur Urol 37:517–520
Wittekind CH, Meyer HJ (2010) TNM. Klassifikation maligner Tumoren. Wiley-Blackwell
Retz M, Gschwend J (2009) MedikamentöseTumortherapie in der Uroonkologie. Springer, Heidelberg
Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (2006) Campbell Walsh Urology Edition. Elsevier Health Sciences
Dechet CB, Zincke H, Sebo TJ et al. (2003) Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol;169: 71–74
Minor LD, Picken MM, Campbell SC et al. (2003) Benign renal tumors. AUA Update 22:170–175
Motzer RJ, Hutson T, Tomczak P et al. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124
Hudes G, Carducci M, Tomczak P et al.; Global ARCC Trial (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356(22): 2271–2281
Escudier B, Eisen T, Stadler WM et al.; the TARGET Study Group (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2): 125–134
Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T (2005) Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev. Jan 25;(1): CD001425
Ljungberg B, Hanbury DC, Kuczyk MA, et al.; European Association of Urology Guideline Group for renal cell carcinoma (2009) Renal cell carcinoma guideline. http://www.uroweb.org/nc/professional-resources/guidelines/online
Volpe A, Panzarella T, Rendon RA et al. (2004) The natural history of incidentally detected small renal masses. Cancer 15:738–745
Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML, Charboneau JW (2008) Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 179(6): 2136–40
Klingler HC (2007) Kidney cancer: energy ablation. Curr Opin Urol 17(5): 322–6, Review
Rini BI, Halabi S, Rosenberg JE et al. (2008) Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206, J Clin Oncol 26(33): 5422–8
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Rohde, V. (2010). Benigne Nierentumoren. In: Facharztwissen Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01626-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-01626-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01625-7
Online ISBN: 978-3-642-01626-4
eBook Packages: Medicine (German Language)